Skip to main content
gpcr multidimensional hero
Application Note

Multidimensional screening platform of GPCR-targeting compounds with HTRF assays

GPCR signaling is inherently multidimensional, and single-endpoint assays may overlook critical pharmacological responses. Discover how combining HTRF™ cAMP, IP-One and GTP/Gi assays provides a comprehensive characterization of receptor activity across Gαs, Gαq and Gαi pathways.

Key takeaways:

  • Assess GPCR activity across multiple signaling pathways using a unified HTRF workflow.
  • Differentiate agonist pharmacology through orthogonal functional readouts.
  • Gain deeper insights into receptor biology to support hit identification and lead optimization.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA

Enter the characters shown in the image.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Multidimensional screening platform of GPCR-targeting compounds with HTRF assays

Revvity AI Assistant Beta

Scroll Icon